S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
SA
INSIDER · 2 COMPANIES · DIRECTOR

Schwab Andrew J.

Every open-market transaction filed under this name, Aug 18 to Aug 27. The same name appears at more than one issuer; filings don’t say whether it’s one person.

Filings
9
0 buys · 9 sells
Bought
open market, at cost
Sold
$2.6M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 27CAMPCamp4 Therapeutics CorpDirectorSell400,000$4.04$1.6M+11.1%
Aug 21CAMPCamp4 Therapeutics CorpDirectorSell32,018$4.50$144K−0.2%
Aug 20SKYESkye Bioscience, Inc.DirectorSell6,495$0.32$2K
Aug 20CAMPCamp4 Therapeutics CorpDirectorSell114,700$4.54$521K−1.1%
Aug 19SKYESkye Bioscience, Inc.DirectorSell57,476$0.35$20K
Aug 19SKYESkye Bioscience, Inc.DirectorSell10,255$0.35$4K
Aug 19CAMPCamp4 Therapeutics CorpDirectorSell45,147$4.76$215K−5.7%
Aug 18SKYESkye Bioscience, Inc.DirectorSell253,080$0.38$96K
Aug 18SKYESkye Bioscience, Inc.DirectorSell45,090$0.38$17K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.